What’s New in Photon Counting CT?

October 09, 2026 · 3 articles · 3 research themes · covering October 02, 2026 – October 09, 2026

Overview

Across this set of studies, a clear theme is the move from “imaging as a qualitative test” toward more standardized, quantitative, and protocol-aware imaging—especially where contrast use and detector technology can materially affect what clinicians see and measure. The oncology-focused review emphasizes that although guidelines outline modality and timing, real-world intravenous contrast strategies (including contrast administration details and choice of optimal phases) vary across tumor entities and clinical questions, with downstream effects on staging, treatment planning, and response assessment.

In parallel, two articles highlight photon-counting CT as a technology platform that may improve both image quality and clinical safety. The cardiothoracic narrative review synthesizes evidence that photon-counting detector CT can enhance spatial/contrast resolution and provide intrinsic spectral information, potentially enabling lower radiation dose and reduced contrast media volume—advantages particularly relevant for pulmonary and cardiac imaging.

Finally, the prospective PCCT study extends the quantitative frontier by validating CT-derived metrics of vertebral bone marrow adipose tissue against MRI proton density fat fraction. Together, these works suggest that next-generation CT (especially photon-counting systems) is increasingly being leveraged not only for better visualization, but also for reproducible biomarker measurement that could broaden access to clinically meaningful tissue characterization.

---

Oncology Imaging Protocols & Contrast Administration

[Contrast agent strategies in elective oncological imaging].

This article reviewed how intravenous contrast agent strategies are implemented in elective oncological imaging using CT and MRI across different tumor entities and clinical questions. It highlights that while guidelines specify imaging modality and frequency, real-world practice varies—especially in contrast administration and the selection of optimal contrast phases for lesion detection and characterization. The review’s significance is that it frames practical protocol variability as a key factor influencing staging, treatment planning, and response assessment in routine cancer imaging.

Gerwing M, Eisenblätter M · Radiologie (Heidelberg, Germany) · (2026) · View on PubMed ↗

---

Photon-Counting Detector CT (PCD/PCCT) Technology & Performance

Photon-Counting Detector CT in Cardiothoracic Imaging: AJR Expert Panel Narrative Review.

This AJR Expert Panel narrative review assessed the clinical evidence for photon-counting detector (PCD) CT versus conventional energy-integrating detector (EID) CT in cardiothoracic imaging. It reports that PCD CT can improve spatial and contrast resolution and provides intrinsic spectral information, with potential benefits including reduced radiation dose and lower contrast media volume for pulmonary and cardiac assessment. The significance is that it synthesizes how these technical advantages may translate into improved cardiothoracic imaging performance and safer protocols.

Milos RI, Siegel MJ, Bluemke DA et al. · AJR. American journal of roentgenology · (2026) · 1 citations · View on PubMed ↗

---

Quantitative Imaging Biomarkers (Marrow Fat/BMAT) Using CT–MRI Reference Standards

Quantitative assessment of vertebral bone marrow adipose tissue using photon-counting CT compared with MRI.

This prospective study evaluated photon-counting CT (PCCT)–derived quantitative parameters for vertebral bone marrow adipose tissue (BMAT) in adult participants with low back pain, using MRI proton density fat fraction (PDFF) from a 6-echo q-Dixon sequence as the reference standard. PCCT metrics—including virtual non-calcium (VNCa) CT values, VNCa CT fat fraction (CTFF), and standardized 70 keV CT values—were compared for correlation and agreement with vertebral and subject-level MRI PDFF. The clinical significance is that PCCT may provide an accurate, CT-based alternative for quantifying BMAT, potentially enabling broader and more accessible assessment of marrow fat changes relevant to musculoskeletal health.

Shu D, Wang J, Liang D et al. · European journal of radiology · (2026) · View on PubMed ↗

---

---

Generated automatically on October 09, 2026. Covers PubMed articles published October 02, 2026 – October 09, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.